Fidelity Investments’s Century Therapeutics IPSC Stock Holding History

Fidelity Investments’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.8K	Sell	8,779 -62,761	-88%	-$132K	﹤0.01%	4517
2025 Q4	$71.2K	Sell	71,540 -120,599	-63%	-$73.6K	﹤0.01%	3927
2025 Q3	$95.7K	Sell	192,139 -828,475	-81%	-$447K	﹤0.01%	3682
2025 Q2	$570K	Sell	1,020,614 -1,574,131	-61%	-$845K	﹤0.01%	2910
2025 Q1	$1.24M	Buy	2,594,745 +60,871	+2%	+$45.7K	﹤0.01%	2607
2024 Q4	$2.56M	Buy	2,533,874 +12,363	+0.5%	+$16.8K	﹤0.01%	2362
2024 Q3	$4.31M	Sell	2,521,511 -428,768	-15%	-$840K	﹤0.01%	2175
2024 Q2	$7.52M	Sell	2,950,279 -420,949	-12%	-$1.33M	﹤0.01%	1953
2024 Q1	$14.1M	Sell	3,371,228 -241,323	-7%	-$1.02M	﹤0.01%	1774
2023 Q4	$12M	Sell	3,612,551 -912,078	-20%	-$1.66M	﹤0.01%	1791
2023 Q3	$9.05M	Sell	4,524,629 -643,866	-12%	-$1.71M	﹤0.01%	1850
2023 Q2	$16.3M	Sell	5,168,495 -174,488	-3%	-$562K	﹤0.01%	1717
2023 Q1	$18.5M	Sell	5,342,983 -1,753,428	-25%	-$7.7M	﹤0.01%	1635
2022 Q4	$36.4M	Sell	7,096,411 -131,890	-2%	-$1.24M	﹤0.01%	1384
2022 Q3	$71.5M	Sell	7,228,301 -348,084	-5%	-$3.67M	0.01%	1087
2022 Q2	$63.6M	Sell	7,576,385 -652,906	-8%	-$6.4M	0.01%	1156
2022 Q1	$104M	Buy	8,229,291 +33,088	+0.4%	+$438K	0.01%	1052
2021 Q4	$130M	Buy	8,196,203 +35,619	+0.4%	+$669K	0.01%	986
2021 Q3	$203M	Buy	8,160,584 +3,201,173	+65%	+$86.6M	0.02%	803
2021 Q2	$141M	Buy	+4,959,411	New	+$126M	0.01%	971

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Fidelity Investments's IPSC Position: Q1 2026 in Review

Fidelity Investments reduced its Century Therapeutics (IPSC) stake by 88% in Q1 2026, selling an estimated $132K and leaving 8,779 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

Fidelity Investments first reported a position in IPSC in Q2 2021 and has held it in 20 quarters since. The position peaked at $203M in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Fidelity Investments held 8,779 shares of Century Therapeutics worth $19.8K as of Q1 2026.
Fidelity Investments sold 62,761 Century Therapeutics shares in Q1 2026, an estimated $132K.
Century Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4517 holding.
Fidelity Investments first reported a position in Century Therapeutics in Q2 2021 and has held it in 20 quarters since.
Fidelity Investments's Century Therapeutics position peaked at $203M in Q3 2021.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.